// App-Quantinova.ai

BSH2020‐PO‐180 : The CAVEaT multicentre audit of venous thrombosis in patients with haematolical malignancy and thrombocytopenia: preliminary results.

Researchers

Presenter

  • S. Booth

Principal Investigators

  • J. Grant-Casey

  • M. Desborough

  • H. Emms

  • N. Curry

  • S. Stanworth

Medical Centers

  • Haematology, OXFORD UNIVERSITY HOSPITALS, Oxford

  • The HaemSTAR Network, UK

  • National Comparative Audit of Blood Transfusion, NHS Blood and Transplant, Oxford, United Kingdom

  • Guy’s and St. Thomas’ NHS Foundation Trust

  • St Georges University Hospitals NHS Foundation Trust, London, UK

  • Dept of Haematology, Oxford University Hospitals NHS Foundation Trust

  • NHS Blood and Transplant

  • Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Oncology (ONC)

Disease

  • Acute promyelocytic leukemia

  • Venous thrombosis

  • Thrombocytopenia

  • Acute Leukemia

  • Multiple Myeloma

  • Solid malignancies

Biomarkers

  • Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Epsilon

Drug/Treatment

  • Heparin

  • Asparaginase

  • Heparin

Outcome

  • N/A

Study Design

  • Multinational

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved